PCM
Prelude Capital Management Portfolio holdings
AUM
$1.02B
1-Year Return
30.93%
This Quarter Return
+10.89%
1 Year Return
+30.93%
3 Year Return
+112.01%
5 Year Return
+170.21%
10 Year Return
+650.33%
AUM
$632M
AUM Growth
+$187M
(+42%)
Cap. Flow
+$70.5M
Cap. Flow
% of AUM
11.16%
Top 10 Holdings %
Top 10 Hldgs %
20.26%
Holding
1,889
New
702
Increased
297
Reduced
216
Closed
332
Top Buys
| 1 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$24.4M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$8.38M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$7.02M |
| 4 |
Broadcom
AVGO
|
+$5.75M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$4.67M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$16.1M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$11.4M |
| 3 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
+$11.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$10.3M |
| 5 |
Micron Technology
MU
|
+$9.51M |
Sector Composition
| 1 | Technology | 20.09% |
| 2 | Consumer Discretionary | 14.44% |
| 3 | Healthcare | 9.84% |
| 4 | Financials | 8.51% |
| 5 | Industrials | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
CSG Systems International
CSGS
$1.88B
| $36K | ﹤0.01% |
877
-7
| -0.8% | -$287 |
|
852
Calavo Growers
CVGW
$495M
| $36K | ﹤0.01% |
+575
| New | +$36K |
|
853
Extreme Networks
EXTR
$2.99B
| $36K | ﹤0.01% |
8,286
| – | – |
|
854
NVR
NVR
$23.6B
| $36K | ﹤0.01% |
11
-12
| -52% | -$39.3K |
|
855
Marriott Vacations Worldwide
VAC
$2.73B
| $36K | ﹤0.01% |
440
+226
| +106% | +$18.5K |
|
856
Financial Select Sector SPDR Fund
XLF
$54.7B
| $36K | ﹤0.01% |
+1,538
| New | +$36K |
|
857
Xencor
XNCR
$600M
| $36K | ﹤0.01% |
+1,107
| New | +$36K |
|
858
Inogen
INGN
$231M
| $35K | ﹤0.01% |
977
-200
| -17% | -$7.17K |
|
859
AAR Corp
AIR
$2.7B
| $34K | ﹤0.01% |
1,637
+100
| +7% | +$2.08K |
|
860
Designer Brands
DBI
$225M
| $34K | ﹤0.01% |
+5,040
| New | +$34K |
|
|
CPE
861
DELISTED
Callon Petroleum Company
CPE
| $34K | ﹤0.01% |
+2,959
| New | +$34K |
|
862
Ligand Pharmaceuticals
LGND
$3.28B
| $33K | ﹤0.01% |
466
+62
| +15% | +$4.39K |
|
863
Otis Worldwide
OTIS
$34.9B
| $33K | ﹤0.01% |
+580
| New | +$33K |
|
864
Expeditors International
EXPD
$16.7B
| $32K | ﹤0.01% |
+424
| New | +$32K |
|
865
Interactive Brokers
IBKR
$28.1B
| $32K | ﹤0.01% |
+3,064
| New | +$32K |
|
866
Molina Healthcare
MOH
$10.3B
| $32K | ﹤0.01% |
180
-342
| -66% | -$60.8K |
|
867
Nutrien
NTR
$27.9B
| $32K | ﹤0.01% |
997
+765
| +330% | +$24.6K |
|
868
Evercore
EVR
$13.1B
| $31K | ﹤0.01% |
+519
| New | +$31K |
|
869
Medifast
MED
$153M
| $31K | ﹤0.01% |
+220
| New | +$31K |
|
870
Watts Water Technologies
WTS
$9.43B
| $31K | ﹤0.01% |
+379
| New | +$31K |
|
|
LTHM
871
DELISTED
Livent Corporation
LTHM
| $31K | ﹤0.01% |
+5,067
| New | +$31K |
|
872
Bausch Health
BHC
$2.67B
| $30K | ﹤0.01% |
1,648
+229
| +16% | +$4.17K |
|
873
Chemours
CC
$2.49B
| $30K | ﹤0.01% |
+1,950
| New | +$30K |
|
874
HEICO Class A
HEI.A
$35.2B
| $30K | ﹤0.01% |
+371
| New | +$30K |
|
875
M/I Homes
MHO
$4.1B
| $30K | ﹤0.01% |
872
-88
| -9% | -$3.03K |
|